« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 5
, Pages
726-732
, May 2009
Lower Thoracic Spinal Cord Stimulation to Restore Cough in Patients With Spinal Cord Injury: Results of a National Institutes of Health–Sponsored Clinical Trial. Part II: Clinical Outcomes
-
Subject responses to frequency of need for conventional means of secretion clearance, severity of cough episodes, difficulty in raising secretions, need for aerosol bronchodilator medications, and eas
Subject responses to frequency of need for conventional means of secretion clearance, severity of cough episodes, difficulty in raising secretions, need for aerosol bronchodilator medications, and ease in raising sputum. With the exception of need for bronchodilator medication, there were significant improvements in all other parameters of secretion management at week 28. This improvement was maintained at week 40. *P<.01 compared to Initial.
-
Subject responses to life quality assessment related to secretion management. There was significant improvement in most parameters at weeks 28 and 40 (P<.01). Improvements in overall health and life qSubject responses to life quality assessment related to secretion management. There was significant improvement in most parameters at weeks 28 and 40 (P<.01). Improvements in overall health and life quality, however, were not statistically significant. *P<.01 compared to Initial.
-
There were significant reductions in the need for caregiver support (A) and significant reductions in the incidence of acute respiratory tract infections (B) after use of the cough system. *P<.01.There were significant reductions in the need for caregiver support (A) and significant reductions in the incidence of acute respiratory tract infections (B) after use of the cough system. *P<.01.
Supported by the National Institute of Neurological Disorders and Stroke (grant no. R01 NS049516) and the National Center for Research Resources (grant no. M01 RR00080 and UL1 RR024989).
Clinical Trial Registration Number: NCT00116337.
We certify that we have affiliations with or financial involvement (eg, employment, consultancies, honoraria, stock ownership or options, expert testimony, grants and patents received or pending, royalties) with an organization or entity with a financial interest in, or financial conflict with, the subject matter or materials discussed in the article. Dr. DiMarco is a Founder of and has a significant financial interest in Synapse BioMedical, Inc, a manufacturer of diaphragm pacing systems.
Reprints are not available from the author.
PII: S0003-9993(09)00124-5
doi: 10.1016/j.apmr.2008.11.014
© 2009 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 5
, Pages
726-732
, May 2009
